Navigation Links
CSA Medical, Inc. Announces 75th Customer
Date:9/20/2010

BALTIMORE, Sept. 20 /PRNewswire/ -- CSA Medical, Inc. announced today that New York University Langone Medical Center (NYU) has begun providing Spray Cryotherapy treatment for patients. Dr. Costas (Gus) Bizekis, Assistant Professor of Medicine, in the department of Cardiothoracic Surgery is performing this procedure. Dr. Bizekis is the Director of Esophageal Surgery in the Department of Cardiothoracic Surgery at NYU Langone Medical Center.  Dr. Bizekis has extensive experience in all aspects of esophageal disease management.

"Spray Cryotherapy is an exciting addition to the tools offered at NYU as it is a minimally invasive (endoscopic) approach that is very patient friendly," says Dr. Bizekis. "We freeze and kill the unwanted tissue with very little pain and patients can generally return to work the next day. Some patients are not candidates for surgery or they have failed to respond to other treatments like chemotherapy and radiation and spray cryotherapy gives us another option. Recently published data also demonstrates it to be safe and effective as a first-line or primary therapy."

Spray cryotherapy utilizes ultra-cold (-196 degrees C) liquid nitrogen delivered in a low pressure spray to freeze and destroy unwanted tissue in the body.

"We are thrilled to have NYU as our 75th customer. It is fitting that such a world-class, patient centered, integrated academic medical center would mark a landmark event for the company" said Ric Hughen, Vice President-Sales & Marketing. "NYU joins a group of preeminent medical centers on the leading edge of new technology adoption for the benefit of their patients".

CSA Medical, Inc. develops and manufactures a proprietary therapeutic interventional platform, the CryoSpray Ablation™ System.  The CSA System utilizes a patented spray cryogenic technology that allows a physician to freeze and destroy a wide range of unwanted tissues via an endoscope.

For more information, please contact Richard Hughen at rhughen@csamedical.com or www.CSAmedical.com.


'/>"/>
SOURCE CSA Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Len DeBenedictis Retires as Chief Technology Officer of Solta Medical, Inc.
2. BlueDot Medical, Inc. Named to 2010 Inc. 500/5000
3. BINDER BIOMEDICAL, INC. Announces Official Launch of the NEWTON™ Intervertebral Body Fusion Spinal Spacer System
4. Solta Medical, Inc. Announces Second Quarter 2010 Results Release Date and Conference Call
5. Halt Medical, Inc. Receives FDA Clearance
6. Apnex Medical, Inc. Names Chas McKhann President, Chief Executive Officer
7. Binder Biomedical, Inc. Announces the Release of the X-GRAFT(TM) Interspinous Device, as Part of Their QUANTUM(TM) Line of Spinal Allograft Devices, Manufactured at the University of Miami Tissue Bank
8. TriReme Medical, Inc. Receives FDA 510K Clearance for Glider(TM) PTA Balloon Catheter
9. Chinas leading electronic systems design event to highlight next-generation medical, automotive and green power technologies
10. Solta Medical, Inc. Announces Fourth Quarter 2009 Results Release Date and Conference Call
11. Tenaxis Medical, Inc. Announces Completion of the Enrollment Phase of Their Pivotal Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016 Research and Markets has announced ... Diagnostic Tests" report to their offering. ... The World Market for Companion Diagnostics covers ... Market analysis in the report includes the following: ... Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
Breaking Medicine Technology:
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... ... , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys ... peers for this recognition are considered among the top 2 percent of lawyers practicing ... members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are ... Code Talker Award, an essay contest in which patients and their families pay tribute ... presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) ...
Breaking Medicine News(10 mins):